Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis.

Link to article at PubMed

Icon for Elsevier Science Related Articles

Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis.

Clin Microbiol Infect. 2019 Oct 24;:

Authors: Pang L, Zhao X, Dickens BL, Lim JT, Cook AR, Netea MG, Donnelly JP, Herbrecht R, Johnson EM, Maertens JA, Kullberg BJ, Troke PF, Marr KA, Chai LYA

OBJECTIVE: In invasive aspergillosis (IA), monitoring response to anti-fungal treatment is challenging. We aimed to explore if routine blood parameters help to anticipate outcomes following IA.
METHODS: Post-hoc secondary analysis of two multicenter randomized trials was performed. The Global Comparative Aspergillosis Study (GCA, N=123) and the Combination Antifungal Study (CAS, N=251) constituted the discovery and validation cohorts respectively. The outcome measures were response to treatment and survival to 12 weeks. Interval platelet, galactomannan index (GMI) and C-reactive protein (CRP) levels prior and during anti-fungal treatment were analyzed using logistic regression, Kaplan-Meier survival and ROC analyses.
RESULTS: The 12-week survival was 70.7% and 63.7% for the GCA and CAS cohorts respectively. In the GCA cohort, every 10×109/L platelet count increase at week 2 and 4 improved 12-week survival odds by 6-18% (Odds ratio [OR] 1.06-1.18, 95% confidence interval [CI] 1.02-1.33). Survival odds also improved 13% with every 10 mg/dL CRP drop at week 1 and 2 (OR 0.87, 95% CI 0.78-0.97). In the CAS cohort, week 2 platelet count was also associated with 12-week survival with 10% improved odds for every 10×109/L platelet increase (OR, 1.10, 95% CI, 1.04-1.15). A GMI drop of 0.1 units was additionally found to increase the odds of treatment response by 3% at the baseline of week 0 (OR 0.97, 95% CI, 0.95-0.99). Week 2 platelet and CRP levels performed better than GMI on ROC analyses for survival (area under ROC curve 0.76, 0.87 and 0.67 respectively). A baseline platelet count higher than 30×109/L clearly identified patients with > 75% survival probability.
CONCLUSIONS: Higher serial platelets were associated with overall survival while GMI trends were linked to IA treatment response. Routine and simple laboratory indices may aid follow-up of response in IA patients.

PMID: 31669427 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.